Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 2D-to-3D Culture and Organoids 2020

Terry Riss's Biography



Terry Riss, Global Strategic Marketing Manager Cell Health, Promega Corporation

Dr. Riss received a PhD in Cell Biology from the University of Illinois in 1978 in the field of mammary gland biology. He did postdoctoral work at the University of Texas Medical School developing bioassays to study breast cancer. Dr. Riss moved to the Biotechnology division of Schering Plough in 1988 to develop interleukin/cytokine bioassays to support IND filings. Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 where he has held several R&D and Project Management positions. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and lead efforts to promote multiplexing of cell-based assays to determine the mechanism of cell death. Dr. Riss now serves as Global Strategic Manager, Cell Health involved in outreach educational training activities. Dr. Riss serves as a co-editor of the NIH Assay Guidance Manual.

Terry Riss Image

Selecting and Validating Fit-for-Purpose Assays to Interrogate 3D Culture Models

Thursday, 20 August 2020 at 08:30

Add to Calendar ▼2020-08-20 08:30:002020-08-20 09:30:00Europe/LondonSelecting and Validating Fit-for-Purpose Assays to Interrogate 3D Culture Models2D-to-3D Culture and Organoids 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

There is a rapid expansion in the use of 3D cell culture model systems ranging from individual scaffold-free spheroids to multiple organoids designed to represent a human-on-a-chip. Researchers soon become aware the spectrum of 3D models have vastly different culture requirements and there is no “one size fits all” approach. Selecting a 3D culture model that is “fit for purpose” often involves compromises considering sample throughput, complexity, physiological relevance, cost and limitations in the available assay technologies. I will describe an overview of factors to consider when designing an appropriate 3D culture model and stress the importance of considering limitations of assay methods to interrogate relatively large 3D structures.


Add to Calendar ▼2020-08-19 00:00:002020-08-20 00:00:00Europe/London2D-to-3D Culture and Organoids 20202D-to-3D Culture and Organoids 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com